Drugs / UI018
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05085184 | Sep → Nov 2021 | hyperlipidemia, combined, 2 | Korea United Pharm. Inc. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UI018 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05085184 ↗ |